Provided by Tiger Trade Technology Pte. Ltd.

Geron

1.40
-0.1400-9.09%
Post-market: 1.410.0100+0.71%19:57 EDT
Volume:19.25M
Turnover:27.99M
Market Cap:893.70M
PE:-11.18
High:1.54
Open:1.51
Low:1.40
Close:1.54
52wk High:2.01
52wk Low:1.04
Shares:638.36M
Float Shares:534.08M
Volume Ratio:0.87
T/O Rate:3.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1252
EPS(LYR):-0.1252
ROE:-32.99%
ROA:-5.53%
PB:3.96
PE(LYR):-11.18

Loading ...

Geron Corp - 2026 Rytelo (Imetelstat) Net Product Revenue Expected in the Range of $220 to $240 Million

THOMSON REUTERS
·
Jan 12

Geron Corp - 2026 Operating Expenses Expected Between $230 Mln and $240 Mln

THOMSON REUTERS
·
Jan 12

Geron Corp - Enters First Amendment to Loan Agreement - SEC Filing

THOMSON REUTERS
·
Jan 06

Geron Extends $250 Million Loan Facility Terms With Pharmakon Funds

Reuters
·
Jan 06

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Dec 19, 2025

Investor Says He 'Doubled' His Savings After Using ChatGPT in Stock Research – Shares Top 5 Stock Picks

Benzinga_recent_news
·
Dec 19, 2025

Geron Corp - Begins Strategic Restructuring Plan - SEC Filing

THOMSON REUTERS
·
Dec 17, 2025

Geron Corporation Announces Workforce Reduction and $18 Million Restructuring Charge

Reuters
·
Dec 17, 2025

Geron Shares up 2.3% Premarket; Co Announces Strategic Restructuring Plan to Reduce Workforce by One-Third

THOMSON REUTERS
·
Dec 11, 2025

BRIEF-Geron Corporation Announces Strategic Restructuring Plan To Position The Company For Long-Term Value Creation

Reuters
·
Dec 11, 2025

Geron Corporation Cuts Workforce by One-Third in Strategic Restructuring

Reuters
·
Dec 11, 2025

Geron Corp - 2026 Operating Expenses Expected to Be Less Than 2025

THOMSON REUTERS
·
Dec 11, 2025

Geron Corp - Restructuring Plan to Reduce Workforce by One-Third

THOMSON REUTERS
·
Dec 11, 2025

Geron Corp - to Incur Cash-Based Restructuring Charges

THOMSON REUTERS
·
Dec 11, 2025

Geron Corp: Reduction in Geron's Current Workforce of About 260 Employees

THOMSON REUTERS
·
Dec 11, 2025

Geron Corp: Restructuring Plan Is Expected to Be Substantially Complete in Q1 of 2026

THOMSON REUTERS
·
Dec 11, 2025

Press Release: Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation

Dow Jones
·
Dec 11, 2025

Geron Corporation Reports on IL-8 and TNF-Alpha Correlation with Survival in Myelofibrosis Patients Treated with Imetelstat

Reuters
·
Dec 08, 2025

Geron Corporation Releases Phase 1b Trial Results on Imetelstat Plus Ruxolitinib for Myelofibrosis

Reuters
·
Dec 08, 2025

Geron Corporation publishes analysis on imetelstat treatment-emergent cytopenias and clinical response in lower-risk myelodysplastic syndromes

Reuters
·
Dec 08, 2025